Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 22, Issue 3

May-June 2025

In this Issue

Ask the Hematologists
Clinical Trials Corner
Committee Corner
Diffusion
Feature
Headlines from Washington
Mini Review
President’s Column

Ask the Hematologists

Viscoelastic Testing for Perioperative Bleeding Management

Jerrold H. Levy, MD,Ian Welsby, MBBS

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Clinical Trials Corner

Can Abelacimab Attenuate the Risk of Bleeding in Patients With Atrial Fibrillation?

Michael Scott, MD, MHPE

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Committee Corner

Committee Corner
The ASH Foundation Is a Reflection of the Society

James Labelle, MD, PhD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Diffusion

Better Together? Combining Teclistamab and Talquetamab in RedirecTT-1

Darren Pan, MD,Anupama D. Kumar, MD,Jodi J. Lipof, MD,Alfred Chung, MD,Ajai Chari, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Scott Furlan, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia

Tycel Phillips, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Debunking the Myth: Sickle Cell Trait and Exertion-Related Deaths — A Review of the Evidence

Chinonso Onuoha, MD,Samuel R. Wilson, MD, MSCR,Patrick Ellsworth, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Emily Wolf, MD,Ewa Wysokinska, MD,Surbhi Shah, MBBS, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Will CAR T Cells Ever Work in Acute Myeloid Leukemia? Perhaps, If We Follow the Cytokines

Lori Muffly, MD, MS

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CRISPR-Based Diagnostic Assay for Acute Promyelocytic Leukemia

Elizabeth L. Courville, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma

Zachary Graff, MD,Lauren Pommert, MD, MS

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments

Brian T. Hill, MD, PhD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Feature

Truly COSMIC: An ASH Research Collaborative First

Saad Usmani, MD, MBA,Shaji Kumar, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Headlines from Washington

ASH Advocacy Continues in Wake of Political Uncertainty

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Mini Review

Technology Spotlight
New Dimensions for Platelet Evaluation in Hematology Diagnostics

Sean X. Gu, MD, PhD,Robert D. Bona, MD,John Hwa, MD, PhD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

President’s Column

Stand Up and Be Counted

Belinda R. Avalos, MD

View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments

Technology Spotlight
New Dimensions for Platelet Evaluation in Hematology Diagnostics

Viscoelastic Testing for Perioperative Bleeding Management

Committee Corner
The ASH Foundation Is a Reflection of the Society

Truly COSMIC: An ASH Research Collaborative First

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologists

Viscoelastic Testing for Perioperative Bleeding Management

Clinical Trials Corner

Can Abelacimab Attenuate the Risk of Bleeding in Patients With Atrial Fibrillation?

Committee Corner

Committee Corner
The ASH Foundation Is a Reflection of the Society

Diffusion

Better Together? Combining Teclistamab and Talquetamab in RedirecTT-1

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Does 1 + 1 = 2? Combining Targeted Agents in Frontline Chronic Lymphocytic Leukemia

Debunking the Myth: Sickle Cell Trait and Exertion-Related Deaths — A Review of the Evidence

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

Will CAR T Cells Ever Work in Acute Myeloid Leukemia? Perhaps, If We Follow the Cytokines

CRISPR-Based Diagnostic Assay for Acute Promyelocytic Leukemia

DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma

Best in Class? DLBclass, a New Classification Tool for Diffuse Large B-Cell Lymphoma to Facilitate Development of Molecular-Based Precision Treatments

Feature

Truly COSMIC: An ASH Research Collaborative First

Headlines from Washington

ASH Advocacy Continues in Wake of Political Uncertainty

Mini Review

Technology Spotlight
New Dimensions for Platelet Evaluation in Hematology Diagnostics

President’s Column

Stand Up and Be Counted

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologists

Clinical Trials Corner

Committee Corner

Diffusion

Feature

Headlines from Washington

Mini Review

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only